Insider · CIK 0001810475

Brown Victoria L.

Reports to the SEC for 1 company · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001810475

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-01-20	APLSApellis Pharmaceuticals, Inc.F Tax Payment	Program Team Lead	FTax Payment	−1,412 sh	$52.05	−$73.5K	23,556
2022-10-26	APLSApellis Pharmaceuticals, Inc.F Tax Payment	Program Team Lead	FTax Payment	−130 sh	$58.41	−$7,593.3	24,844
2022-06-17	APLSApellis Pharmaceuticals, Inc.S Sale	Program Team Lead	SSale	−2,698 sh	$45.00	−$121K	24,974
2022-03-25	APLSApellis Pharmaceuticals, Inc.F Tax Payment	Program Team Lead	FTax Payment	−82 sh	$49.28	−$4,040.96	28,325
2022-02-10	APLSApellis Pharmaceuticals, Inc.F Tax Payment	Program Team Lead	FTax Payment	−175 sh	$47.12	−$8,246	28,407
2022-01-28	APLSApellis Pharmaceuticals, Inc.F Tax Payment	Program Team Lead	FTax Payment	−434 sh	$38.59	−$16.7K	28,582
2022-01-21	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Program Team Lead	AAward	+24.8K sh	—	—	24,774
2022-01-21	APLSApellis Pharmaceuticals, Inc.A Award	Program Team Lead	AAward	+17.5K sh	—	—	29,016
2021-10-26	APLSApellis Pharmaceuticals, Inc.A Award	Program Team Lead	AAward	+882 sh	—	—	11,422
2021-03-25	APLSApellis Pharmaceuticals, Inc.F Tax Payment	Program Team Lead	FTax Payment	−82 sh	$41.16	−$3,375.12	9,952
2021-03-01	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Program Team Lead	AAward	+7,500 sh	—	—	7,500
2021-03-01	APLSApellis Pharmaceuticals, Inc.A Award	Program Team Lead	AAward	+1,250 sh	—	—	10,034
2021-02-10	APLSApellis Pharmaceuticals, Inc.F Tax Payment	Program Team Lead	FTax Payment	−144 sh	$47.72	−$6,871.68	8,784
2021-01-28	APLSApellis Pharmaceuticals, Inc.A Award	Program Team Lead	AAward	+5,000 sh	—	—	8,928
2021-01-28	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Program Team Lead	AAward	+30K sh	—	—	30,000
2020-10-07	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Program Team Lead	MExercise/Conversion	−12K sh	—	—	39,268
2020-10-07	APLSApellis Pharmaceuticals, Inc.S Sale	Program Team Lead	SSale	−12K sh	$35.00	−$420K	3,607
2020-10-07	APLSApellis Pharmaceuticals, Inc.M Exercise/Conversion	Program Team Lead	MExercise/Conversion	+12K sh	$18.98	+$228K	15,607

Recent filings

Accepted (ET)
Jan 244
Brown Victoria L.0001127602-23-002109
SEC(opens sec.gov)
Oct 284
Brown Victoria L.0000899243-22-034414
SEC(opens sec.gov)
Jun 224
Brown Victoria L.0001127602-22-017990
SEC(opens sec.gov)
Mar 294
Brown Victoria L.0001127602-22-010532
SEC(opens sec.gov)
Feb 144
Brown Victoria L.0001127602-22-004777
SEC(opens sec.gov)
Feb 14
Brown Victoria L.0001127602-22-002817
SEC(opens sec.gov)
Jan 254
Brown Victoria L.0001127602-22-002058
SEC(opens sec.gov)
Oct 274
Brown Victoria L.0001127602-21-027695
SEC(opens sec.gov)
Mar 294
Brown Victoria L.0001127602-21-012242
SEC(opens sec.gov)
Mar 194
Brown Victoria L.0001127602-21-011597
SEC(opens sec.gov)
Feb 114
Brown Victoria L.0001127602-21-005203
SEC(opens sec.gov)
Feb 14
Brown Victoria L.0001127602-21-003232
SEC(opens sec.gov)
Oct 94
Brown Victoria L.0001127602-20-026748
SEC(opens sec.gov)

Companies

Apellis Pharmaceuticals, Inc.Program Team LeadAPLS

Address

C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR

WALTHAM, MA, 02451